Drug · DIN 02485613
OXERVATE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 17, 2024; first marketed February 18, 2022.
- Drug Identification Number (DIN)
- 02485613
- Company (DIN owner)
- Dompé Farmaceutici S.P.A.Milano, Milan, Italy
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Cenegermin S01XA24
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CENEGERMIN | 0.002 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 8, 2019: NOC 21856New Drug Submission (NDS)